4//SEC Filing
Lawton Alison Frances 4
Accession 0001209191-21-039228
CIK 0001636282other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:24 PM ET
Size
5.5 KB
Accession
0001209191-21-039228
Insider Transaction Report
Form 4
LAWTON ALISON FRANCIS
Director
Transactions
- Award
Director Stock Option (right to buy)
2021-06-08+40,000→ 40,000 totalExercise: $6.80Exp: 2031-06-07→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001542650
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:24 PM ET
- Size
- 5.5 KB